AG˹ٷ

STOCK TITAN

[Form 4] Phibro Animal Health Corporation Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Insider grant of restricted stock units to a senior officer at Phibro Animal Health (PAHC). Lisa Ann Escudero, Senior Vice President, Human Resources, was awarded 2,152 restricted stock units (RSUs) on 08/15/2025. Each RSU represents the contingent right to receive one share of Class A Common Stock and was reported with a transaction code indicating a grant at $0. The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2025, provided the reporting person remains employed through each vesting date. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 08/19/2025.

Concessione insider di unità azionarie vincolate a un dirigente di Phibro Animal Health (PAHC). Il 15/08/2025 a Lisa Ann Escudero, Senior Vice President, Human Resources, sono state assegnate 2.152 unità azionarie vincolate (RSU). Ciascuna RSU dà il diritto condizionato a ricevere una azione di Class A Common Stock ed è stata registrata come una concessione a $0. Le RSU maturano in quote sostanzialmente uguali nelle prime tre ricorrenze annuali del 1° agosto 2025, a condizione che la beneficiaria sia ancora impiegata ad ogni data di maturazione. Il Modulo 4 è stato firmato per delega da un procuratore il 19/08/2025.

Otorgamiento interno de unidades restringidas a un alto ejecutivo de Phibro Animal Health (PAHC). El 15/08/2025 se concedieron a Lisa Ann Escudero, Senior Vice President, Human Resources, 2.152 unidades restringidas (RSU). Cada RSU otorga el derecho contingente a recibir una acción de Class A Common Stock y la transacción se declaró como una concesión a $0. Las RSU se consolidan en cuotas aproximadamente iguales en los tres primeros aniversarios del 1 de agosto de 2025, siempre que la interesada permanezca empleada en cada fecha de consolidación. El Formulario 4 fue firmado por un apoderado en nombre de la interesada el 19/08/2025.

Phibro Animal Health(PAHC)� 고위 임원� 대� 내부� 제한주식단위(RSU) 부�. 2025� 8� 15일자� 인사총괄 부사장 Lisa Ann Escudero에게 2,152개의 제한주식단위(RSU)가 부여되었습니다. � RSU� 클래� A 보통주의 주식 1주를 받을 � 있는 조건부 권리� 의미하며, 거래� $0� 보고되었습니�. RSU� 2025� 8� 1일을 시작으로 � 3� 기념일마� 거의 동일� 비율� 취득되며, 보고대상자가 � 취득일에 계속 고용되어 있어� 합니�. 해당 Form 4� 2025� 8� 19일에 대리인� 보고대상자� 대신해 서명했습니다.

Attribution interne d'unités d'actions restreintes à un cadre supérieur de Phibro Animal Health (PAHC). Le 15/08/2025, Lisa Ann Escudero, Senior Vice President, Human Resources, s'est vu attribuer 2 152 unités d'actions restreintes (RSU). Chaque RSU confère le droit conditionnel de recevoir une action de Class A Common Stock et la transaction a été déclarée comme une attribution à 0 $. Les RSU sont acquises en parts sensiblement égales lors des trois premières dates anniversaire du 1er août 2025, à condition que la bénéficiaire reste employée à chaque date d'acquisition. Le formulaire 4 a été signé par un mandataire au nom de la déclarente le 19/08/2025.

Insider-Zuweisung von Restricted Stock Units an eine Führungskraft bei Phibro Animal Health (PAHC). Am 15.08.2025 wurden Lisa Ann Escudero, Senior Vice President, Human Resources, 2.152 Restricted Stock Units (RSUs) zugewiesen. Jede RSU berechtigt bedingt zum Erhalt einer Aktie der Class A Common Stock und wurde als Zuteilung zu $0 gemeldet. Die RSUs werden in im Wesentlichen gleichen Teilen an den ersten drei Jahrestagen des 1. August 2025 unverfallbar, vorausgesetzt, die betroffene Person bleibt jeweils bis zum jeweiligen Vesting-Datum beschäftigt. Das Formular 4 wurde am 19.08.2025 von einem Bevollmächtigten im Namen der meldepflichtigen Person unterschrieben.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine equity-based compensation grant to a senior HR officer; not a market-moving event.

The 2,152 RSU award is a standard, non-cash compensation mechanism that aligns the executive with shareholder interests by delivering shares subject to multi-year vesting. The grant price reported as $0 reflects a compensation grant rather than an open-market purchase. Vesting over three annual installments introduces retention incentives but creates only a modest potential dilution relative to total outstanding shares (dilution percentage not provided in the filing). No sale or open-market transaction was reported here.

TL;DR: Governance-wise this is a standard officer RSU award with time-based vesting and routine disclosure.

The Form 4 discloses a time-based award to a named officer, consistent with typical compensation practices. The filing includes vesting schedule details which support transparency about the conditions under which shares will be issued. There is no indication of performance-based acceleration or special vesting events in the disclosure, and the form was executed by an attorney-in-fact as permitted by Form 4 rules.

Concessione insider di unità azionarie vincolate a un dirigente di Phibro Animal Health (PAHC). Il 15/08/2025 a Lisa Ann Escudero, Senior Vice President, Human Resources, sono state assegnate 2.152 unità azionarie vincolate (RSU). Ciascuna RSU dà il diritto condizionato a ricevere una azione di Class A Common Stock ed è stata registrata come una concessione a $0. Le RSU maturano in quote sostanzialmente uguali nelle prime tre ricorrenze annuali del 1° agosto 2025, a condizione che la beneficiaria sia ancora impiegata ad ogni data di maturazione. Il Modulo 4 è stato firmato per delega da un procuratore il 19/08/2025.

Otorgamiento interno de unidades restringidas a un alto ejecutivo de Phibro Animal Health (PAHC). El 15/08/2025 se concedieron a Lisa Ann Escudero, Senior Vice President, Human Resources, 2.152 unidades restringidas (RSU). Cada RSU otorga el derecho contingente a recibir una acción de Class A Common Stock y la transacción se declaró como una concesión a $0. Las RSU se consolidan en cuotas aproximadamente iguales en los tres primeros aniversarios del 1 de agosto de 2025, siempre que la interesada permanezca empleada en cada fecha de consolidación. El Formulario 4 fue firmado por un apoderado en nombre de la interesada el 19/08/2025.

Phibro Animal Health(PAHC)� 고위 임원� 대� 내부� 제한주식단위(RSU) 부�. 2025� 8� 15일자� 인사총괄 부사장 Lisa Ann Escudero에게 2,152개의 제한주식단위(RSU)가 부여되었습니다. � RSU� 클래� A 보통주의 주식 1주를 받을 � 있는 조건부 권리� 의미하며, 거래� $0� 보고되었습니�. RSU� 2025� 8� 1일을 시작으로 � 3� 기념일마� 거의 동일� 비율� 취득되며, 보고대상자가 � 취득일에 계속 고용되어 있어� 합니�. 해당 Form 4� 2025� 8� 19일에 대리인� 보고대상자� 대신해 서명했습니다.

Attribution interne d'unités d'actions restreintes à un cadre supérieur de Phibro Animal Health (PAHC). Le 15/08/2025, Lisa Ann Escudero, Senior Vice President, Human Resources, s'est vu attribuer 2 152 unités d'actions restreintes (RSU). Chaque RSU confère le droit conditionnel de recevoir une action de Class A Common Stock et la transaction a été déclarée comme une attribution à 0 $. Les RSU sont acquises en parts sensiblement égales lors des trois premières dates anniversaire du 1er août 2025, à condition que la bénéficiaire reste employée à chaque date d'acquisition. Le formulaire 4 a été signé par un mandataire au nom de la déclarente le 19/08/2025.

Insider-Zuweisung von Restricted Stock Units an eine Führungskraft bei Phibro Animal Health (PAHC). Am 15.08.2025 wurden Lisa Ann Escudero, Senior Vice President, Human Resources, 2.152 Restricted Stock Units (RSUs) zugewiesen. Jede RSU berechtigt bedingt zum Erhalt einer Aktie der Class A Common Stock und wurde als Zuteilung zu $0 gemeldet. Die RSUs werden in im Wesentlichen gleichen Teilen an den ersten drei Jahrestagen des 1. August 2025 unverfallbar, vorausgesetzt, die betroffene Person bleibt jeweils bis zum jeweiligen Vesting-Datum beschäftigt. Das Formular 4 wurde am 19.08.2025 von einem Bevollmächtigten im Namen der meldepflichtigen Person unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Escudero Lisa Ann

(Last) (First) (Middle)
300 FRANK W. BURR BLVD., STE 21

(Street)
TEANECK NJ 07666

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PHIBRO ANIMAL HEALTH CORP [ PAHC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
See Remarks
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock(1) 08/15/2025 A 2,152(2) A $0 2,152 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of Class A Common Stock.
2. The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2025, subject to the Reporting Person's continued employment through the applicable vesting date.
Remarks:
Senior Vice President, Human Resources. Exhibit List - Exhibit 24.1 Power of Attorney
/s/ Judith Weinstein, as Attorney-in-Fact for Lisa Ann Escudero 08/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Phibro Animal

NASDAQ:PAHC

PAHC Rankings

PAHC Latest News

PAHC Latest SEC Filings

PAHC Stock Data

1.27B
20.22M
0.59%
104.36%
2.53%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
United States
TEANECK